JSK Biomed
Daejeon · Founded 2015
About JSK Biomed
JSK Biomed focuses on the research and development of bio-medical devices. Their primary product, Mirage Jet, is a unique needle-free injector designed for anti-aging treatments. This innovative device enables the transdermal delivery of drugs without the use of needles, providing a safe and effective solution for their users. In addition to this, JSK Biomed is committed to the development of cutting-edge bio-equipment and the advancement of transdermal drug delivery systems.
Company Facts
- Founded: 2015
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $986.9K
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2020)
- Website: https://www.jskbiomed.com
Industries & Categories
Health Care, Medical, Medical Device
Canonical: https://fsome.com/organization/jsk-biomed-81439 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.